2021 annual financial data
Regencell Bioscience 2021 Net margin
Regencell Bioscience 2021 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -1,381,362 USD and net income was -1,346,745 USD.
Operating cash flow was -767,311 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,381,362 USD
- Net income
- -1,346,745 USD
- Operating cash flow
- -767,311 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Regencell Bioscience financial years